Applications of 1-((Pyrrolidine-1-Carbonyl)Methyl)Piperazine in Industrial Manufacturing

As a dedicated manufacturer of 1-((Pyrrolidine-1-Carbonyl)Methyl)Piperazine, we supply this intermediate to downstream industries where it supports structurally advanced molecule synthesis and high-value end products. Our manufacturing partners rely on us for reliable supply, technical transparency, and proven quality in demanding applications. Below, we detail key industrial scenarios where this specialty amide finds irreplaceable utility, including compliance with relevant regulations, typical formulation parameters, industrial integration points, and types of downstream finished goods.

1. Pharmaceutical Intermediate for Heterocyclic Drug Synthesis

1-((Pyrrolidine-1-Carbonyl)Methyl)Piperazine serves as a critical building block for complex heterocyclic active pharmaceutical ingredient (API) development, primarily in the synthesis of piperazine or pyrrolidine-substituted drugs. It enables modular functionalization in multi-step organic syntheses, supporting selectivity and yield improvements for patent-protected medications. Drug manufacturers incorporate this raw material during nitrogen heterocycle formation, which directly determines final pharmacological characteristics.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• USP–NF Monographs (where relevant to downstream synthesized APIs)
• European Pharmacopoeia applicable monographs
• 21 CFR Part 210 and 211 FDA cGMP for finished pharmaceuticals

Typical usage ratio

• 0.5–3.5 molar equivalents relative to the main drug core; adjusted based on stepwise substitution and scale-up pilot results

Downstream process integration

• Charged into nitrogen heterocycle introduction stage following key functional group protection steps; often subjected to amide coupling, N-alkylation, or reductive amination depending on the specific pharmaceutical route

Final product types

• Oral tablet and capsule prescription medications incorporating piperazine or pyrrolidine scaffolds
• Specialty drug substances requiring advanced cyclic amide motifs

2. Agrochemical Active Ingredient Synthesis

The material is widely used in the multi-stage fabrication of select fungicides, insecticides, and plant growth regulators where piperazine-carboxamide segments modulate biological activity. Downstream processors employ it as a key structural intermediate, introducing target-specific moieties and enhancing chemical stability of final crop protection compounds produced via controlled organic synthesis pathways.

Industry compliance standards

• FAO/WHO Specifications for Plant Protection Products
• OECD Principles of Good Laboratory Practice (GLP) for test batch qualification
• REACH Registration, Evaluation, Authorization, and Restriction of Chemicals (Europe)
• SANCO/3030/99 Guidelines for pesticide active substance production

Typical usage ratio

• 1.0–5.0 wt% of the active ingredient precursor mass; adjustments made based on crop protection product concentration goals and active loading requirements

Downstream process integration

• Dosed during N-heterocyclic scaffolding after key functionalization steps; used prior to final cyclization, chlorination, or esterification depending on the agrochemical’s mode of action

Final product types

• Emulsifiable concentrate and wettable powder pesticide formulations
• Seed treatment agents and systemic crop protection solutions

3. Specialty Polyamide Resin Modifier

Formulators of engineering polymers employ this compound to fine-tune the mechanical and chemical profile of polyamide resins. It acts as a chain-interrupting or branching monomer during condensation polymerization, affecting glass transition temperature, elasticity, and solvent resistance in downstream technical plastics production.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems (implemented at resin manufacturing plants)
• RoHS Directive 2011/65/EU for electronics polymer applications
• REACH SVHC screening for plastic additives above regulatory thresholds
• ASTM D4066 for Nylon and polyamide technical grade quality

Typical usage ratio

• 0.3–2.0 wt% of total monomer mass, dosage optimized for end-use property tuning through lab-scale compounding

Downstream process integration

• Fed into melt polymerization reactors as a minor comonomer during the polycondensation of lactams or diamines; enters before catalyst addition to avoid side reactions and maintain molecular weight control

Final product types

• High-performance polyamide engineering plastics
• Specialized molded parts for automotive, electrical, and industrial fittings

4. Intermediate for API Reference Standards and Impurity Profiling

Reference laboratories and pharmaceutical QC divisions use this compound to synthesize trace-level related substances and impurities for regulatory documentation, batch release, and stability testing. Its defined structure enables targeted synthesis of analytical standards critical for method validation and pharmacopoeial compliance in regulated pharmaceutical workflows.

Industry compliance standards

• USP General Chapter <741> for Melting Range or Temperature
• Ph.Eur. 5.10 for Impurities: Guidelines for Setting Specifications
• ICH Q3A/B for Impurities in New Drug Substances and Products
• ISO/IEC 17025:2017 for laboratory calibration and testing

Typical usage ratio

• Sub-gram to multi-gram scale; usually 0.01–0.5 wt% as a synthetic impurity or comparator spike in QC sample

Downstream process integration

• Used during stepwise impurity synthesis or reference standard preparation; introduced during specific impurity-forming reactions or for comparison with process-derived byproducts

Final product types

• Pharmaceutical analytical reference standards
• Validated impurity markers for chromatographic or spectroscopic identification